Table 3.
Polypharmacy among community-dwelling elderly in Lomé, Togo in 2017.
| Polypharmacy 1∗ | Polypharmacy 2∗∗ | |||||
|---|---|---|---|---|---|---|
| n/N | % | p | n/N | % | p | |
| Overall prevalence | 63/369 | 17.1 | 84/368 | 22.8 | ||
| Sex | 0.210 | 0.049 | ||||
| Male | 24/167 | 14.4 | 30/166 | 18.1 | ||
| Female | 39/202 | 19.3 | 54/202 | 26.7 | ||
|
| ||||||
| Age | 0.434 | 0.906 | ||||
| ≤65 years | 23/151 | 15.2 | 34/151 | 22.5 | ||
| >65 years | 40/218 | 18.3 | 50/217 | 23.0 | ||
|
| ||||||
| Marital status | 0.477 | 0.895 | ||||
| Married/Living with a partner | 39/213 | 18.3 | 48/212 | 22.6 | ||
| Living alone | 24/155 | 15.4 | 36/155 | 23.2 | ||
|
| ||||||
| Educational level | 0.05 | 0.325 | ||||
| None | 10/99 | 10.1 | 17/99 | 17.2 | ||
| Primary school | 18/107 | 16.8 | 25/107 | 23.4 | ||
| Secondary school | 25/100 | 25.0 | 28/99 | 28.3 | ||
| University | 10/60 | 16.7 | 14/60 | 23.3 | ||
|
| ||||||
| Monthly revenue | 0.188 | 0.654 | ||||
| <150€ | 39/257 | 15.2 | 55/256 | 21.5 | ||
| (150–450) | 15/77 | 19.5 | 16/77 | 20.8 | ||
| >450€ | 6/20 | 30.0 | 6/20 | 30.0 | ||
|
| ||||||
| Medical conditions | ||||||
| Hypertension | 43/187 | 23.0 | 0.002 | 50/186 | 26.9 | 0.061 |
| Other CVD | 21/50 | 42.0 | <0.001 | 26/50 | 52.0 | <0.001 |
| Diabetes | 19/67 | 28.4 | 0.007 | 22/66 | 33.3 | 0.025 |
| Osteoarthritis | 49/218 | 22.5 | 0.001 | 61/217 | 28.1 | 0.004 |
| Visual impairment | 19/46 | 41.3 | <0.001 | 21/46 | 45.7 | <0.001 |
| Dyslipidemia | 17/42 | 40.5 | <0.001 | 19/42 | 45.2 | <0.001 |
|
| ||||||
| Multimorbidity | 58/213 | 27.2 | <0.001 | 70/212 | 33.0 | <0.001 |
∗Polypharmacy 1: number of medications ≥5, not including medicinal plants and other dietary supplements. ∗∗Polypharmacy 2: number of medications ≥5, including medicinal plants and other dietary supplements. CVD = cardiovascular disease.